Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-10-7
pubmed:abstractText
Bone mass is maintained through the complementary activities of osteoblasts and osteoclasts; yet differentiation of either osteoblasts and osteoclasts engages the mitogen-activated protein kinase (MAPK) pathway. The MAPKs are negatively regulated by a family of dual-specificity phosphatases known as the MAPK phosphatases (MKPs). MKP-1 is a stress-responsive MKP that inactivates the MAPKs and plays a central role in macrophages; however, whether MKP-1 plays a role in the maintenance of bone mass has yet to be investigated. We show here, using a genetic approach, that mkp-1(-/-) female mice exhibited slightly reduced bone mass. We found that mkp-1(+/+) and mkp-1(-/-) mice had equivalent levels of bone loss after ovariectomy despite mkp-1(-/-) mice having fewer osteoclasts, suggesting that mkp-1(-/-) osteoclasts are hyperactive. Indeed, deletion of MKP1 led to a profound activation of osteoclasts in vivo in response to local lipopolysaccharide (LPS) injection. These results suggest a role for MKP-1 in osteoclasts, which originate from the fusion of macrophages. In support of these observations, receptor activator for nuclear factor-kappaB ligand induced the expression for MKP-1, and osteoclasts derived from mkp-1(-/-) mice had increased resorptive activity. Finally, receptor activator of nuclear factor-kappaB ligand-induced p38 MAPK and c-Jun NH2-terminal kinase activities were enhanced in osteoclasts derived from mkp-1(-/-) mice. Taken together, these results show that MKP-1 plays a role in the maintenance of bone mass and does so by negatively regulating MAPK-dependent osteoclast signaling.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1525-2191
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
175
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1564-73
pubmed:dateRevised
2010-10-4
pubmed:meshHeading
pubmed-meshheading:19762714-Animals, pubmed-meshheading:19762714-Bone Density, pubmed-meshheading:19762714-Bone Resorption, pubmed-meshheading:19762714-Bone and Bones, pubmed-meshheading:19762714-Cell Count, pubmed-meshheading:19762714-Cell Differentiation, pubmed-meshheading:19762714-Dual Specificity Phosphatase 1, pubmed-meshheading:19762714-Enzyme Activation, pubmed-meshheading:19762714-Estrogens, pubmed-meshheading:19762714-Female, pubmed-meshheading:19762714-Homeostasis, pubmed-meshheading:19762714-Injections, pubmed-meshheading:19762714-Lipopolysaccharides, pubmed-meshheading:19762714-Macrophage Colony-Stimulating Factor, pubmed-meshheading:19762714-Male, pubmed-meshheading:19762714-Mice, pubmed-meshheading:19762714-Osteoblasts, pubmed-meshheading:19762714-Osteoclasts, pubmed-meshheading:19762714-Ovariectomy, pubmed-meshheading:19762714-RANK Ligand
pubmed:year
2009
pubmed:articleTitle
Role of MKP-1 in osteoclasts and bone homeostasis.
pubmed:affiliation
Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural